PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 24, 2026˜The œNational Medical Journal of India0 citations

Non-steroidal anti-inflammatory drugs (NSAID)-induced allergic myocardial infarction (Kounis syndrome)

View Full Paper
NNNAVEENKUMAR NALLATHAMBIMKMANIEVELRAAMAN KANNANASANBARASAN SEKAR

Key Points

  • To highlight the under-recognized condition of Kounis syndrome as a cause of allergic myocardial infarction.
  • Reported a case of a middle-aged female post-diclofenac injection
  • Documented symptoms including chest pain and rash
  • Monitored cardiac biomarkers and tryptase levels
  • Administered treatment with epinephrine, steroids, and antihistamines
  • Patient diagnosed with allergic NSTEMI following anaphylactic reaction
  • Elevated tryptase and cardiac biomarkers indicated significant allergic response
  • Prompt treatment led to successful management of the condition

Abstract

Anaphylactic acute coronary syndrome (Kounis syndrome) is under-recognized due to its wide spectrum of manifestations, ranging from asymptomatic cardiac biomarker elevation to frank ST-segment elevation myocardial infarction (STEMI). We report a middle-aged female who developed acute onset chest pain with diffuse maculopapular rash after an injection of diclofenac. In the setting of anaphylaxis, she had elevated tryptase and was diagnosed with allergic non-STEMI (NSTEMI). She was managed with epinephrine, steroids, and antihistamines. Prompt recognition of this clinical entity is vital for its successful treatment.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

NALLATHAMBI et al. (2026) studied this question.

synapsesocial.com/papers/6974610cbb9d90c67120af86https://doi.org/10.25259/nmji_523_2024
Ask AI
Helpful
Bookmark
Share
View Full Paper